Features of the clinical course of a new coronavirus infection in children
- Autores: Turovskaya A.A.1,2, Kostina E.M1, Orlova E.A1, Trushina E.Y.1, Grishanovich G.M2, Sidorova O.G2, Avdoshina E.V2
-
Afiliações:
- Penza Institute for Advanced Medical Education - Branch Campus of the Russian Medical Academy of Continuous Professional Education
- City Children's Polyclinic
- Edição: Volume 29, Nº 9 (2022)
- Páginas: 57-61
- Seção: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/321064
- DOI: https://doi.org/10.18565/pharmateca.2022.9.57-61
- ID: 321064
Citar
Texto integral
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Palavras-chave
Texto integral
Sobre autores
Alina Turovskaya
Penza Institute for Advanced Medical Education - Branch Campus of the Russian Medical Academy of Continuous Professional Education; City Children's Polyclinic
Email: alinaziboreva@yandex.ru
Postgraduate student at the Department of Clinical Immunology and Allergology; Pediatrician Penza, Russia
E. Kostina
Penza Institute for Advanced Medical Education - Branch Campus of the Russian Medical Academy of Continuous Professional EducationPenza, Russia
E. Orlova
Penza Institute for Advanced Medical Education - Branch Campus of the Russian Medical Academy of Continuous Professional EducationPenza, Russia
E. Trushina
Penza Institute for Advanced Medical Education - Branch Campus of the Russian Medical Academy of Continuous Professional EducationPenza, Russia
G. Grishanovich
City Children's PolyclinicPenza, Russia
O. Sidorova
City Children's PolyclinicPenza, Russia
E. Avdoshina
City Children's PolyclinicPenza, Russia
Bibliografia
- Dong Y., Mo X., Hu Y., et al. Epidemiological characteristics of 2143 pediatric patients with 2019 Coronavis Disease in China. Pediatrics. 2020;145(6). doi: 10.1542/peds.2020-0702.
- Намазова-Баранова Л.С. Коронавирусная инфекция (Covid-19) у детей (состояние на апрель 2020). Педиатрическая фармакология. 2020;17(2):85-94. doi: 10.15690/pf.v17i2.2094.
- Snape M.D., Viner R.M. COVID-19 in children and young people. Science. 2020;370(6514):286-88. doi: 10.1126/science.abd6165
- URL: https://coronavirusonline.com.ua/countries/
- URL: https://www.rospotrebnadzor.ru/about/info/predpr/news_predpr.php?ELEMENT_ID=15344&sphrase_id=3165929
- URL: https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/children-and-covid-19-state-level-data-report/
- Временные методические рекомендации: особенности клинических проявлений и лечения заболевания, вызванного новой коронавирусной инфекцией (COVID-19) у детей. Версия 2 (03.07.2020) (Электронный ресурс). URL: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/050/914/original/03062020_%D0%B4%D0%B5%D1%82%D0%B8_COVID-19_v2.pdf
- Alsohimea E., Temsaha M-H., Al-Nemri A.M., et al. COVID-19 infection prevalence in pediatric population: Etiology, clinical presentation, and outcome. J Infect Public Health. 2020;13:1791-96. doi: 10.1016/j.jiph.2020.10.008.
- Mehta N.S., Mytton O., Mullins E., et al. SARS-CoV-2 (COVID-19): What do we know about children? A systematic review. Lancet Inrect Dis. 2020;9(71):2469-79. doi: 10.1093/cid/ciaa556.
- Wu Q., Xing Y., Shi L., et al. Coinfection and other clinical characteristics of COVID-19 in children. Pediatrics. 2020;146(1):1-9. doi: 10.1542/peds.2020-0961.
- Tagarro A., Epalza C., Santos M., et al. Screening and severity of coronavirus disease 2019 (COVID-19) in children in Madrid, Spain. JAMA Pediatr. 2020;174(10):1009. doi: 10.1001/jamapediatrics.2020.1528.
- Miri S.M., Noorbakhsh E., Mohebbi S.R., Ghaemi A. Higher prevalence of asymptomatic or mild COVID-19 in children, claims and clues. J Med Virol. 2020;92(11):1-3. doi: 10.1002/jmv.26069
- Заплатников А.Л., Свинцицкая В.И. COVID-19 и дети. Русский медицинский журнал. 2020;6:20-2.
- Suratannon N., Dik W.A., Chatchatee P., Hagen PM. COVID-19 in children: Heterogeneity within the disease and hypothetical pathogenesis. Asian Pac J Allergy Immunol. 2020;38:170-77. doi: 10.12932/AP-170720-0920.
- Bunyavanich S., Do A., Vicencio A. Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults. JAMA. 2020;323(23):2427-29. doi: 10.1001/jama.2020.8707.
- Moeller A., Thanikkel L., Duijts L., et al. COVID-19 in children with underlying chronic respiratory diseases: survey results from 174 centres. ERJ Open Research. 2020;6(4):00409-2020. doi: 10.1183/23120541.00409-2020.
- Cardona-Hernandez R., Cherubini V., Iafusco D., et al. Children and youth with diabetes are not at increased risk for hospitalization due to COVID-19. Pediatr Diabetes. 2021;22:202-6. doi: 10.1111/pedi.13158.
- Александрович Ю.С., Байбарина Е.Н., Баранов А.А. и др. Ведение детей с заболеванием, вызванным новой коронавирусной инфекцией (SARS-CoV-2). Педиатрическая фармакология. 2020;17(2):103-18. doi: 10.15690/pf.v17i2.2096.
- Ramakrishnan S., Nicolau D.V., Langford B., Mahdi M. Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial. Lancet Respir Med. 2021;9(7):763-72. doi: 10.1016/S2213-2600(21)00160-0.
- Castro-Rodriguez J.A. Asthma and COVID-19 in children: A systematic review and call for data. Pediatr Pulmonol. 2020;55(9):2412-18. doi: 10.1002/ppul.24909.
- Arden K.E., Chang A.B., Lambert S.B., et al. Newly identified respiratory viruses in children with asthma exacerbation not requiring admission to hospital. J Med Virol. 2010;82:1458-61. doi: 10.1002/jmv.21819.